Evaluation of radioiodinated histamine as isotope carrier in vivo

Nuclear Medicine Communications

Volumn 21, Issue 5, 2000, Pages 459-468

  Garnuszek, P ^a   Licinska, I ^a   Mazurek, A P ^a  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ANIMAL; ARTICLE; CHEMISTRY; DRUG STABILITY; MALE; MOUSE; RAT; TISSUE DISTRIBUTION; URINE; WISTAR RAT;

ANIMALS; DRUG STABILITY; HISTAMINE; IODINE RADIOISOTOPES; MALE; MICE; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; TISSUE DISTRIBUTION;

EID: 0034180717     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200005000-00009     Document Type: Article

References (18)

1. Nars PW, Hunter WM. A method of labelling oestradiol-17β with radioiodine for radioimmunoassay. J Endocr 1973; 57: XLVII.
2. 125I-labelled ligands in steroid radioimmunoassay. Biochem Soc Trans 1973; 1: 1115-1117.
3. 125I]-iodohistamine-labelled steroid derivatives as radioligands for radioimmunoassay of natural and synthetic steroids. J Steroid Biochem 1981; 14: 53-62.
4. 125I-labeled-histamine-cyclosporin c for monitoring serum cyclosporine concentrations in transplantation patients. Clin Chem 1986; 32: 492-495.
5. 125I-labelled tracers for radioimmunoassay of haptens: general approach? J Immunol Meth 1982; 51: 159-166.
6. Chambers VEM, ed. Radiolabelled steroids. Amersham International Review 21. London: Whitefriars Press, 1980.
7. Dewanjee MK, ed. Radioiodination: Theory, practice, and bio-medical applications Boston, MA: Kluwer Academic, 1992.
8. Bolton AE, ed. Radioiodination techniques, 2nd edn. Amersham International Review 18. Amersham: Amersham International, 1985.
9. Spencer RP, Seevers Jr RH, Friedman AM, eds. Radionuclides in therapy. Boca Raton, FL: CRC Press, 1987.
10. Tominaga M, Paiva ACM. Iodinated derivatives of histamine and N-acetylhistamine. J Med Chem 1969; 12: 693-694.
11. Garnuszek P, LiciDska I, Fiedor P, Mazurek AP. The synthesis, radioiodination and preliminary biological study of the new carboxylic derivatives of dithizone. Appl Radiat Isot 1998; 49: 1563-1571.
12. Janevik-Ivanovska E, Gautherot E, Hillairet de Boisferon M et al. Bivalent hapten-bearing peptides designed for iodine-131 pretargeted radioimmunotherapy. Bioconjug Chem 1997; 8: 526-533.
13. Bukusoglu C, Krieger NR. Estrogen-specific target site identified by progesterone-11 alpha-hemisuccinate-(2-[125I]-iodohistamine) in mouse brain membranes. J Steroid Biochem Mol Biol 1996; 58: 89-94.
14. Fujibayashi Y, Takemura Y, Matsumoto K et al. High myocardial accumulation of radioiodinated digoxin derivative: A possible Na,K-ATPase imaging agent. J Nucl Med 1992; 33: 545-549.
15. 125I-2-iodohistamine for radioimmunoassay. Prep Biochem 1979; 9: 379-390.
16. Ganellin CR, Parsons ME, eds. Pharmacology of histamine receptors. Bristol: Wright, 1982: 29-35.
17. 2 receptors. In Schwartz JC, Haas HL, eds. The histamine receptors. New York: Wiley-Liss, 1992: 1-56.
18. Painter K, Vader CR. Interference of iodine-125 ligands in radioimmunoassay: Evidence implicating thyroxine-binding globulin. Clin Chem 1979; 25: 797-799.